S&P 500   4,549.78
DOW   35,603.08
QQQ   377.27
S&P 500   4,549.78
DOW   35,603.08
QQQ   377.27
S&P 500   4,549.78
DOW   35,603.08
QQQ   377.27
S&P 500   4,549.78
DOW   35,603.08
QQQ   377.27
LON:PRTC

PureTech Health Share Forecast, Price & News

GBX 345.50
-1.50 (-0.43 %)
(As of 10/22/2021 11:23 AM ET)
Add
Compare
Today's Range
339.80
347
50-Day Range
321
366.50
52-Week Range
232.01
447.66
Volume33,946 shs
Average Volume195,425 shs
Market Capitalization£990.04 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.


PureTech Health logo

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
300
Year Founded
N/A

Sales & Book Value

Annual Sales
£10.76 million
Cash Flow
GBX 150.28 per share
Book Value
GBX 198.20 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
£990.04 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.70 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












PureTech Health (LON:PRTC) Frequently Asked Questions

Is PureTech Health a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PureTech Health in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PureTech Health stock.
View analyst ratings for PureTech Health
or view top-rated stocks.

What stocks does MarketBeat like better than PureTech Health?

Wall Street analysts have given PureTech Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PureTech Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has PureTech Health's stock price been impacted by Coronavirus (COVID-19)?

PureTech Health's stock was trading at GBX 274 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PRTC shares have increased by 26.1% and is now trading at GBX 345.50.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for PRTC?

4 brokerages have issued 1-year price targets for PureTech Health's stock. Their forecasts range from GBX 475 to GBX 930. On average, they anticipate PureTech Health's share price to reach GBX 718.75 in the next twelve months. This suggests a possible upside of 108.0% from the stock's current price.
View analysts' price targets for PureTech Health
or view top-rated stocks among Wall Street analysts.

Who are PureTech Health's key executives?

PureTech Health's management team includes the following people:
  • Ms. Daphne Zohar, Founder, CEO & Exec. Director (Age 47)
  • Dr. Bennett M. Shapiro, Co-Founder & Non-Exec. Director (Age 78)
  • Dr. Robert S. Langer Jr., Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board (Age 69)
  • Mr. Stephen M. Muniz J.D., COO, Exec. VP of Legal & Operations, Sec. and Exec. Director (Age 48)
  • Dr. Bharatt M. Chowrira, Pres and Chief of Bus. & Strategy (Age 53)

What other stocks do shareholders of PureTech Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PureTech Health investors own include Nemaska Lithium (NMX), Yamana Gold (YRI), Asanko Gold (AKG), Arotech (ARTX), The Boeing (BA), Baozun (BZUN), Chaarat Gold (CGH), Eldorado Gold (ELD), CarMax (KMX) and Knowles (KN).

What is PureTech Health's stock symbol?

PureTech Health trades on the London Stock Exchange (LON) under the ticker symbol "PRTC."

How do I buy shares of PureTech Health?

Shares of PRTC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is PureTech Health's stock price today?

One share of PRTC stock can currently be purchased for approximately GBX 345.50.

How much money does PureTech Health make?

PureTech Health has a market capitalization of £990.04 million and generates £10.76 million in revenue each year.

How many employees does PureTech Health have?

PureTech Health employs 300 workers across the globe.

What is PureTech Health's official website?

The official website for PureTech Health is puretechhealth.com.

Where are PureTech Health's headquarters?

How can I contact PureTech Health?

PureTech Health's mailing address is 501 Boylston St Ste 6102, BOSTON, MA 02116-3769, United States. The company can be reached via phone at +1-617-4822333.


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.